Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Tumor treating fields in the management of Glioblastoma: opportunities for advanced imaging.

Soni VS, Yanagihara TK.

Cancer Imaging. 2019 Nov 29;19(1):76. doi: 10.1186/s40644-019-0259-8. Review.

2.

The effects of alternating electric fields in glioblastoma: current evidence on therapeutic mechanisms and clinical outcomes.

Rehman AA, Elmore KB, Mattei TA.

Neurosurg Focus. 2015 Mar;38(3):E14. doi: 10.3171/2015.1.FOCUS14742. Review.

PMID:
25727223
3.

Integration of Tumor-Treating Fields into the Multidisciplinary Management of Patients with Solid Malignancies.

Wang Y, Pandey M, Ballo MT.

Oncologist. 2019 Dec;24(12):e1426-e1436. doi: 10.1634/theoncologist.2017-0603. Epub 2019 Aug 23. Review.

4.

Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies.

Mittal S, Klinger NV, Michelhaugh SK, Barger GR, Pannullo SC, Juhász C.

J Neurosurg. 2018 Feb;128(2):414-421. doi: 10.3171/2016.9.JNS16452. Epub 2017 Feb 24.

5.

Tumor treating fields: a novel and effective therapy for glioblastoma: mechanism, efficacy, safety and future perspectives.

Zhu P, Zhu JJ.

Chin Clin Oncol. 2017 Aug;6(4):41. doi: 10.21037/cco.2017.06.29. Review.

6.

Tumor treating fields therapy device for glioblastoma: physics and clinical practice considerations.

Lok E, Swanson KD, Wong ET.

Expert Rev Med Devices. 2015;12(6):717-26. doi: 10.1586/17434440.2015.1086641. Epub 2015 Oct 29. Review.

PMID:
26513694
7.

Tumor treating fields: a new frontier in cancer therapy.

Davies AM, Weinberg U, Palti Y.

Ann N Y Acad Sci. 2013 Jul;1291:86-95. doi: 10.1111/nyas.12112. Epub 2013 May 9. Review.

PMID:
23659608
8.

The Evolving Role of Tumor Treating Fields in Managing Glioblastoma: Guide for Oncologists.

Burri SH, Gondi V, Brown PD, Mehta MP.

Am J Clin Oncol. 2018 Feb;41(2):191-196. doi: 10.1097/COC.0000000000000395. Review.

9.

Alternating Electric Fields (“Tumour-Treating Fields”) for the Treatment of Glioblastoma.

Topfer LA, Farrah K.

CADTH Issues in Emerging Health Technologies. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016-. 165.

10.

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.

Stupp R, Taillibert S, Kanner A, Read W, Steinberg D, Lhermitte B, Toms S, Idbaih A, Ahluwalia MS, Fink K, Di Meco F, Lieberman F, Zhu JJ, Stragliotto G, Tran D, Brem S, Hottinger A, Kirson ED, Lavy-Shahaf G, Weinberg U, Kim CY, Paek SH, Nicholas G, Bruna J, Hirte H, Weller M, Palti Y, Hegi ME, Ram Z.

JAMA. 2017 Dec 19;318(23):2306-2316. doi: 10.1001/jama.2017.18718. Erratum in: JAMA. 2018 May 1;319(17):1824.

11.

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology.

Stroke. 2003 Aug;34(8):e109-37. Epub 2003 Jul 17. Erratum in: Stroke. 2003 Nov;34(11):2774.

PMID:
12869717
12.

Response patterns of recurrent glioblastomas treated with tumor-treating fields.

Vymazal J, Wong ET.

Semin Oncol. 2014 Oct;41 Suppl 6:S14-24. doi: 10.1053/j.seminoncol.2014.09.009. Epub 2014 Sep 16. Erratum in: Semin Oncol. 2015 Jun;42(3):e44-55.

13.

Tumor treating fields: concept, evidence and future.

Pless M, Weinberg U.

Expert Opin Investig Drugs. 2011 Aug;20(8):1099-106. doi: 10.1517/13543784.2011.583236. Epub 2011 May 9. Review.

PMID:
21548832
14.

Outside the box--novel therapeutic strategies for glioblastoma.

Mrugala MM, Adair JE, Kiem HP.

Cancer J. 2012 Jan-Feb;18(1):51-8. doi: 10.1097/PPO.0b013e318243f785. Review.

PMID:
22290258
15.

Resolution of cystic enhancement to add-on tumor treating electric fields for recurrent glioblastoma after incomplete response to bevacizumab.

Elzinga G, Wong ET.

Case Rep Neurol. 2014 Apr 5;6(1):109-15. doi: 10.1159/000362264. eCollection 2014 Jan.

16.
17.

Computed modeling of alternating electric fields therapy for recurrent glioblastoma.

Lok E, Hua V, Wong ET.

Cancer Med. 2015 Nov;4(11):1697-9. doi: 10.1002/cam4.519. Epub 2015 Aug 26.

18.

A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma.

Trusheim J, Dunbar E, Battiste J, Iwamoto F, Mohile N, Damek D, Bota DA, Connelly J.

CNS Oncol. 2017 Jan;6(1):29-43. doi: 10.2217/cns-2016-0032. Epub 2016 Sep 15. Review.

19.

Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial.

Toms SA, Kim CY, Nicholas G, Ram Z.

J Neurooncol. 2019 Jan;141(2):467-473. doi: 10.1007/s11060-018-03057-z. Epub 2018 Dec 1.

20.

Tumor treating fields: a new approach to glioblastoma therapy.

Rick J, Chandra A, Aghi MK.

J Neurooncol. 2018 May;137(3):447-453. doi: 10.1007/s11060-018-2768-x. Epub 2018 Jan 18. Review.

PMID:
29349613

Supplemental Content

Support Center